Standard Follow-Up Program for Brain Tumor Patients
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new follow-up program for people with brain or spinal tumors who are getting radiation therapy. The program aims to improve your care and monitor your recovery after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain or spinal tumor (neuro-oncological cancer).
- You are receiving a specific dose of radiation therapy (like 54 Gy or 60 Gy).
- You are willing to follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a standard follow-up program for people with breast cancer who are getting radiotherapy. It aims to see how well the program supports patients after treatment.
This trial studies a standard follow-up plan to help you stay on track after radiation treatment for lung cancers or certain related conditions. It may help your care team monitor symptoms and outcomes in a consistent way.
This trial tests a standard follow-up plan for people who have esophageal cancer and received a certain amount of radiation. It may help your care team monitor side effects and catch health changes early.
This trial sets up a standard schedule for follow-up visits for people receiving curative (aimed at cure) or after-surgery radiotherapy for head and neck cancer. It may help you stay on track with regular check-ins and early management of side effects or signs of recurrence.
This trial studies a standard follow-up plan for people who are treated with radiation with the goal of cure for cervical cancer. It may help your care team monitor recovery, side effects, and overall health over time.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
Hear when a new Neurological Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.